Insulin icodec is an investigational ultralong-acting basal insulin analogue.
Insulin icodec is a synthetic peptide analog of human insulin, engineered to possess an extended half-life and unique pharmacokinetic properties through specific structural modifications. As a long-acting insulin derivative, it features strategic amino acid substitutions and fatty acid acylation, which enhance its albumin binding and enable gradual, sustained release. The compound is of considerable interest in biochemical and pharmaceutical research due to its distinctive molecular design, which allows for the exploration of protracted insulin action mechanisms, protein engineering strategies, and advanced peptide formulation methodologies. Its robust stability and altered receptor interaction profile make it a valuable tool for dissecting the molecular underpinnings of insulin signaling and for developing innovative delivery systems.
Peptide engineering research: Insulin icodec serves as a model for studying the structure-function relationships in peptide therapeutics, particularly in the context of half-life extension strategies. Researchers utilize this analog to investigate how specific amino acid modifications and lipid conjugation confer prolonged circulatory persistence. Such studies inform the rational design of next-generation peptide drugs with optimized pharmacokinetics, providing insight into the balance between receptor affinity, metabolic stability, and bioavailability.
Receptor binding and signaling studies: Due to its engineered modifications, this insulin analog is frequently employed to analyze insulin receptor engagement and downstream signaling dynamics. By comparing its receptor binding kinetics and activation profiles to those of native insulin, scientists can elucidate the effects of structural changes on receptor selectivity, signal transduction efficiency, and cellular response modulation. These investigations contribute to a deeper understanding of insulin signaling pathways and the development of analogs with tailored biological activity.
Protein-protein interaction analysis: The strong albumin-binding capacity of insulin icodec, resulting from its fatty acid side chain, provides a platform for exploring protein-protein interactions in the context of drug delivery and extended-release formulations. Experimental systems incorporating this analog allow for the quantification and characterization of albumin-peptide binding kinetics, informing the design of albumin-conjugated therapeutics and advancing knowledge of carrier-mediated pharmacokinetics.
Peptide formulation development: The unique physicochemical properties of this long-acting insulin analog make it an instructive candidate in the field of peptide formulation science. Researchers leverage its stability and solubility characteristics to optimize excipient selection, delivery vehicles, and controlled-release technologies. Such work underpins the advancement of peptide-based pharmaceuticals by addressing challenges related to aggregation, degradation, and sustained delivery.
Analytical method validation: Insulin icodec is utilized as a reference compound in the development and validation of analytical methods for peptide quantification and characterization. Its defined structure and modified properties support the calibration and performance assessment of chromatographic, spectrometric, and bioanalytical platforms. These activities are essential for ensuring the accuracy and reproducibility of peptide analysis in research and quality control settings, ultimately facilitating the reliable study of complex peptide analogs.
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More